
Resolute has promoted Kirsty Mearns to the role of director, joining the PR agency’s board. “I am incredibly pleased and …
Genzyme has appointed industry veteran Ron Branning as its new senior vice president of global product quality. Branning has 30 …
World Class Commissioning has been heralded as a critical mechanism to revolutionise healthcare services in the UK. Now two years …
Biogen Idec is seeking European approval for a drug which helps multiple sclerosis sufferers to walk better. A marketing authorisation …
Sanofi-Aventis has appointed Han Regenauer vice president, consumer healthcare, Europe and global development. In his new role he will report …

Canadian clinical research firm MDS has appointed Steve West chief executive. He was formerly president of MDS Nordion and chief …

The Germany Ministry of Health has cut its order for GlaxoSmithKline’s swine flu vaccine Pandemrix by 30%. The pharma company …
The Food and Drug Administration has unveiled the first phase of its transparency initiative, designed to make its drug approval …
Germany’s Evonik Industries has started up production of active pharmaceutical ingredients (APIs) at the Tippecanoe Laboratories facility acquired from Eli …

Eurocom has appointed Rachel Underwood as creative copywriter. She has over ten years of scientific and marketing communications experience and …

Patient group Diabetes UK has, quite literally, set up shop on Second Life, establishing its own office in the online …
A few years ago I met someone who worked at a car factory and he described in detail how the …
It’s a widely-held myth that retaining staff is easy in a recession. As jobs are cut the attraction of staying …
Dublin-headquartered biotech Amarin has appointed Joseph Zakrzewski executive chairman. He is currently the chief executive of Xcellerex, a Massachusetts-based biotechnology …
Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …
This week’s rundown of manufacturing news includes a delay for Mannkind’s inhaled insulin product Afrezza, more job losses at Pfizer …
Ferring Pharmaceuticals and Stiefel Laboratories have been named and shamed for breaching the ABPI Code of Practice. Adverts giving details …
GlaxoSmithKline is to develop and commercialise a drug which hopes will be a treatment for moderate-to-severe Crohn’s disease. Californian biotech …
Novartis has launched its new biologic Ilaris in the UK as a treatment for cryopyrin-associated periodic syndrome. The rare debilitating …
ScopeMedical has appointed Matthew Booth as a senior medical writer. Matt has nearly 10 years of solid experience within academia …